Verona Pharma plc (I9SA) — Tangible Net Worth Ratio
Verona Pharma plc (I9SA) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€278.27 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is Verona Pharma plc growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Verona Pharma plc Tangible Net Worth Ratio (2016–2024)
This chart shows how Verona Pharma plc's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of €278.27 Million with intangible assets of €0.00 EUR. For live market cap and overall valuation, see Verona Pharma plc (I9SA) total market value.
Annual Tangible Net Worth Ratio for Verona Pharma plc (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Verona Pharma plc from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Verona Pharma plc (I9SA) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | €204.56 Million | €0.00 | €474.24 Million | ▲ +0.0 pp |
| 2023 | 100.0% | €249.28 Million | €0.00 | €308.12 Million | ▲ +0.0 pp |
| 2022 | 100.0% | €230.47 Million | €0.00 | €259.47 Million | ▲ +0.0 pp |
| 2021 | 100.0% | €148.00 Million | €0.00 | €186.59 Million | ▲ +0.0 pp |
| 2020 | 100.0% | €184.85 Million | €0.00 | €204.21 Million | ▲ +8.1 pp |
| 2019 | 91.9% | €44.40 Million | €3.61 Million | €59.18 Million | ▼ -4.8 pp |
| 2018 | 96.6% | €79.86 Million | €2.71 Million | €94.23 Million | ▼ -0.9 pp |
| 2017 | 97.5% | €107.95 Million | €2.66 Million | €120.96 Million | ▲ +3.0 pp |
| 2016 | 94.6% | €42.53 Million | €2.32 Million | €56.93 Million | — |